Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06322212
EARLY_PHASE1

Type 2 Diabetes and Blood Brain Barrier Improvement

Sponsor: University of California, Los Angeles

View on ClinicalTrials.gov

Summary

The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

Official title: Type 2 Diabetes Mellitus and Blood Brain Barrier Improvement - A Randomized Clinical Trial

Key Details

Gender

All

Age Range

40 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

52

Start Date

2024-08-01

Completion Date

2027-03-31

Last Updated

2026-03-13

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Thiamine

Participants will be provided instruction to take one 500 mg capsule of Thiamine (Vitamin B1) each day in the morning for 3-months.

OTHER

Placebo

Participants will be provided instruction to take one capsule (placebo) each day in the morning for 3-months.

Locations (1)

UCLA

Los Angeles, California, United States